biomanufacturing jim dekloe
DESCRIPTION
Biomanufacturing Jim DeKloe. Biotechnology is the intersection of Science Business Government. Traditional Pharmaceutical “Big Pharma” Drugs Small molecules Produced by Chemistry Example: Aspirin. Biotechnology companies “Biotech” Proteins Large Molecules - PowerPoint PPT PresentationTRANSCRIPT
Biotechnology 101Business and Regulatory Practices
1
Biomanufacturing
Jim DeKloe
Biotechnology 101Business and Regulatory Practices
2
Biotechnology is the intersection of
Science
Business
Government
Biotechnology 101Business and Regulatory Practices
3
Biotechnology 101Business and Regulatory Practices
4
Drugs versus “biotech”
Traditional Pharmaceutical
“Big Pharma”
Drugs
Small molecules
Produced by Chemistry
Example: Aspirin
Biotechnology companies
“Biotech”
Proteins
Large Molecules
Produced by Living Organisms
Example: EPO
Biotechnology 101Business and Regulatory Practices
5
History
Drugs
Small molecules
Produced by Chemistry
Simple Pure Molecules
Easy to Test Quality
Example: Aspirin
Biologics
Complicated Mixture of Large Molecules
Difficult to Test Purity
Emphasis on Consistent Process
Examples:
Vaccines, Plasma and Serum
Biotechnology 101Business and Regulatory Practices
Technician Training
Biotech clusters thrive when all elements of the industry are represented
Until recently, the emphasis on R & D meant that formal training targeting technicians was rare
Community Colleges have moved into this niche
Technician training will be even more important as more companies move from R & D into biomanufacturing
Biotechnology 101Business and Regulatory Practices
A Model Academic - Industry Collaboration
Building biomanufacturing curriculum
Tailoring curriculum to develop specific required skills
Incorporating regulatory requirements into curriculum
Biotechnology 101Business and Regulatory Practices
Genentech suppliedSabbatical Experience
Expertise
Donated Equipment
Presence on Advisory Committee
Guest Speakers
Biotechnology 101Business and Regulatory Practices
Traditional versus IndustrialTraditional Industrial
Education Training
Lab Atmosphere Pilot Plant Atmosphere
Set Times Shifts
Lab Protocols SOP
Lab Notebook Batch Records
Individual Team
Biotechnology 101Business and Regulatory Practices
Question Authority!Change Academic Paradigm
Borrow vocational tech and business ideas
Teach skills as well as educate
Emulate the industrial experience
Share the ideas that work
Biotechnology 101Business and Regulatory Practices
11
Back to Basics - Cells
Biotechnology 101Business and Regulatory Practices
12
Eukaryotic Cells can be Engineered Also
Biotechnology 101Business and Regulatory Practices
13
Protein!
The Protein is the Product!
Biotechnology 101Business and Regulatory Practices
14
Protein Structure
Proteins can be modified after they are synthesized
The addition of sugars – glycosylation – may be important – it affects solubility and pharmacokinetics (blood half live)
Glycosylation patterns may vary
Repeat because it is so important: If a protein loses this shape, it loses its function
Biotechnology 101Business and Regulatory Practices
15
Protein!
The protein must not be unfolded (denatured) or it loses its function. Proteins can be denatured by:
•pH extremes
•temperature extremes
•organic chemicals
•agitation
Biotechnology 101Business and Regulatory Practices
16
Protein!
DNA is the Flash
Protein is the Cash
Biotechnology 101Business and Regulatory Practices
17
Protein!
DNA is the Show
Protein is the Dough
Biotechnology 101Business and Regulatory Practices
18
Protein!
DNA is the Bling
Protein is the Thing
Biotechnology 101Business and Regulatory Practices
19
Bacterial Cells – Prokaryotic Cells
Biotechnology 101Business and Regulatory Practices
20
Cells are grown in a large scale
Biotechnology 101Business and Regulatory Practices
21
Upstream
Cells Divide and are transferred to larger and larger volumes
Cells are induced to produce protein
Many in-process samples are taken; some are sent to QC for a variety of tests. For mammalian cells, they will check for contamination by viruses and mycoplasma
Biotechnology 101Business and Regulatory Practices
22
Recovery - Downstream
Cells are separated from the medium surrounding them by filtration or centrifugation.
Typically:
In E. coli culture (slang is fermentation), the cells are retained and the medium is discarded
In cell culture (CHO cells), the cells have been engineered to secrete the protein, so the cells are discarded and the protein-containing medium is retained
Biotechnology 101Business and Regulatory Practices
23
Protein Purification
The protein of interest must be separated from the other proteins in the cells or medium until it is 99.99% pure.
This is accomplished by ultrafiltration and chromatography
Biotechnology 101Business and Regulatory Practices
24
Ultrafiltration
In ultrafiltration the protein containing solution is passed through a filter with pores of a defined size. This can separate proteins of different sizes from one another, or can separate protein from medium components.
Biotechnology 101Business and Regulatory Practices
25
Chromatography
Chromatography methods use resins of different types to exploit the characteristics of the protein to interest to separate it from other contaminating protein
Biotechnology 101Business and Regulatory Practices
26
Types of Chromatography
Type of Chromatography Protein Property
•Gel Filtration (Size Exclusion) - Size
•Ion Exchange (Cation or Anion) – Charge
•Hydrophobic Interaction Chrom. – Hydrophobicity
•Affinity Chromatography - Function or Special Characteristic
Biotechnology 101Business and Regulatory Practices
27
Formulation
Once the protein has been purified, the bulk purified protein will be placed in the formulation buffer and sterile filtered. During formulation, adjuncts are added to:
•Stablize pH
•Adjust osmolarity
•Prevent aggregation
•Cryoprotect (for lyophilized products)
Biotechnology 101Business and Regulatory Practices
28
Fill
Fill is completed in a special facility that has highly filtered air, gowned personnel with special training, This process is highly automated.
A measured amount of the formulated protein is aliquoted into sterile ampules
Biotechnology 101Business and Regulatory Practices
29
Finish
The protein may be lyophilized (freeze dried). This makes it more stable, but physicians may find this form of the drug less convenient to use.
Closures are added
Labels are applied.
Biotechnology 101Business and Regulatory Practices
30
Quality Assurance
The law requires a QA/QC department that is separate from manufacturing
They will test:
Raw Materials
In-Process Samples
Utilities
Environmental Monitoring
The final protein product
Biotechnology 101Business and Regulatory Practices
31
Regulation
In the United States, the Food and Drug Administration regulates pharmaceutical production
•Part of the executive branch
•Regulates $ 1 trillion of commerce a year
•Center for Drug Evaluation and Research
•Center for Biologics Evaluation and Research
Biotechnology 101Business and Regulatory Practices
32
What Are GMPs?
Subpart DescriptionA General Provisions
B Organization and Personnel
C Buildings and Facilities
D Equipment
E Control of Components and Drug Product Containers and Closures
F Production and Process Controls
G Packaging and Labeling Controls
H Holding and Distribution
I Laboratory Controls
J Records and Reports
K Returned and Salvaged Drug Products